X-Chromosome-wide association study for Alzheimer’s disease

Julie Le Borgne,Lissette Gomez,Sami Heikkinen,Najaf Amin,Shahzad Ahmad,Seung Hoan Choi,Joshua Bis,Benjamin Grenier-Boley,Omar Garcia Rodriguez,Luca Kleineidam,Juan Young,Kumar Parijat Tripathi,Lily Wang,Achintya Varma,Sven van der Lee,Vincent Damotte,Itziar de Rojas,Sagnik Palmal,Vilmantas Giedraitis,Roberta Ghidoni,Victoria Fernandez,Patrick Gavin Kehoe,Ruth Frikke-Schmidt,Magda Tsolaki,Pascual Sánchez-Juan,Kristel Sleegers,Martin Ingelsson,Jonathan Haines,Lindsay Farrer,Richard Mayeux,Li-San Wang,Rebecca Sims,Anita DeStefano,Gerard D. Schellenberg,Sudha Seshadri,Philippe Amouyel,Julie Williams,Wiesje van der Flier,Alfredo Ramirez,Margaret Pericak-Vance,Ole Andreassen,Cornelia Van Duijn,Mikko Hiltunen,Agustín Ruiz,Josée Dupuis,Eden Martin,Jean-Charles Lambert,Brian Kunkle,Céline Bellenguez
DOI: https://doi.org/10.1101/2024.05.02.24306739
2024-05-03
Abstract:Due to methodological reasons, the X-chromosome has not been featured in the major genome-wide association studies on Alzheimer’s Disease (AD). To finally address this and better characterize the genetic landscape of AD, we performed an in-depth X-Chromosome-Wide Association Study (XWAS) in 115,841 AD cases or AD proxy cases, including 52,214 clinically-diagnosed AD cases, and 613,671 controls. We considered three approaches to account for the different X-chromosome inactivation (XCI) states in females, i.e. random XCI, skewed XCI, and escape XCI. We did not detect any genome-wide significant signals (P ≤ 5 × 10 ) but identified four X-chromosome-wide significant loci (P ≤ 1.7 × 10 ). Two signals locate in the and genes, while the two others are more than 300 kb away from the closest protein coding genes and . Overall, this XWAS found no common genetic risk factors for AD on the non-pseudoautosomal region of the X-chromosome, but it identified suggestive signals warranting further investigations.
Neurology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the association between X - chromosome gene mutations in Alzheimer's disease (AD) and disease risk. Although the X - chromosome accounts for approximately 5% of the size and gene number in the human genome, it is usually excluded from large - scale genome - wide association studies (GWAS) due to technical limitations. Therefore, there are relatively few studies on how X - chromosome gene mutations affect AD risk. By conducting an X - chromosome genome - wide association study (XWAS), this paper aims to fill this knowledge gap and more comprehensively understand the genetic basis of AD, especially the impact of genetic mutations on the X - chromosome on AD risk. Specifically, the researchers utilized data from the International Genomics of Alzheimer's Project (IGAP), the European Alzheimer's Disease and Dementia Biobank (EADB), the UK Biobank, and the FinnGen study, including a total of 115,841 AD cases or AD proxy cases and 613,671 control individuals, to conduct an in - depth X - chromosome genome - wide association analysis. The study considered three different X - chromosome inactivation (XCI) states: random XCI, skewed XCI, and escape XCI, in order to comprehensively assess the impact of genetic mutations on the X - chromosome on AD risk. Through this method, the researchers hope to identify possible genetic risk factors on the X - chromosome and provide clues for further research.